Prevalence of penicillin-non-susceptible Streptococcus pneumoniae in children in day-care centres subjected to an intervention to prevent dispersion

Infectious Diseases
Jonas AhlHåkan Ringberg

Abstract

The aim of this study was to evaluate the day-care interventions implemented in southern Sweden to restrict the dispersion of penicillin-non-susceptible pneumococci with a minimum inhibitory concentration of penicillin G of at least 0.5 mg/l (PNSP0.5). A retrospective epidemiological study was performed and data from 109 day-care centre interventions from 2000 to 2010 were analysed, including screening results from 7157 individuals. It was found that 42% of the children were carriers of pneumococci and 5% of the screened children were PNSP0.5 carriers. Very few personnel were PNSP0.5 carriers and they were carriers for only a short time. Significantly more contact cases with the same serogroup as the index case were found in the first screening and in the same department as the index case, but a substantial number of contact cases were found in adjacent departments. Screening of personnel is not worth the effort. Based on our results, procedures to restrict dispersion of PNSP0.5 in day-care centres could be improved. To find the majority of contact cases with PNSP0.5 an early screening including adjacent departments seems to be the best approach.

References

Jan 1, 1994·Scandinavian Journal of Infectious Diseases·K Ekdahl, C Kamme
Mar 1, 1994·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A Forsgren, M Walder
Jul 3, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·K EkdahlK Persson
Jan 31, 2003·The Journal of Antimicrobial Chemotherapy·J A García-Rodríguez, M J Fresnadillo Martínez
Jun 23, 2004·Emerging Infectious Diseases·Eva MelanderHåkan Ringberg
Sep 17, 2004·Scandinavian Journal of Infectious Diseases·Liselotte HögbergKarl Ekdahl
Jul 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Donald E Low
Sep 28, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vilhjalmur A ArasonKarl G Kristinsson
Sep 21, 2012·Scandinavian Journal of Infectious Diseases·Maria HellbergJonas Ahl
Nov 2, 2012·Scandinavian Journal of Infectious Diseases·Susann SkovbjergChristina Åhrén
Apr 17, 2014·The Pediatric Infectious Disease Journal·Jonas AhlHåkan Ringberg

❮ Previous
Next ❯

Citations

Sep 23, 2020·Antimicrobial Agents and Chemotherapy·Dehua LuoHongping Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Eva MelanderKarl Ekdahl
© 2022 Meta ULC. All rights reserved